Skip to content

Screening for celiac disease in average-risk and high-risk populations

By Alejandro Hahn / January 7, 2019

A review of rifaximin and bacterial overgrowth in poorly responsive celiac disease

Transformation of videocapsule images to detect small bowel mucosal differences in celiac versus control patients

Copyright © 2026 Celiac Disease Center at Columbia University Medical Center

Scroll to Top